TGFB1 and Hepatic fibrosis: Thus, in the current study, it is possible that AdNDRG2 treatment exerted its therapeutic function by antagonizing TGF-β1 and subsequently increasing hepatocyte proliferation without inducing cell apoptosis, processes essential for treating liver fibrosis and improving liver function.